NEW YORK, May 01, 2018 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its first quarter 2018 financial results prior to market open on Tuesday, May 8, 2018. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. Eastern Time to discuss the results.
Intercept management will also be presenting at the following upcoming investor conferences:
- Deutsche Bank 43rd Annual Health Care Conference at 9:20 a.m. ET on Wednesday, May 9, 2018
- Bank of America Merrill Lynch 2018 Healthcare Conference at 5:00 p.m. PT on Tuesday, May 15, 2018
- UBS Global Healthcare Conference at 3:00 p.m. ET on Monday, May 21, 2018
- Jefferies 2018 Global Healthcare Conference at 9:00 a.m. ET on Friday, June 8, 2018
Webcast information for these events will be available on the investor page of Intercept's website at http://ir.interceptpharma.com. Archived webcasts will be available on Intercept's website for approximately two weeks.
About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.
CONTACT
For more information about Intercept Pharmaceuticals, please contact:
Mark Vignola
+1-646-747-1000
[email protected]
Media inquiries: [email protected]


Medical Groups Sue FTC Over Gender-Affirming Care Investigations Amid Trump Policy Dispute
Disney Issues Cease-and-Desist to ByteDance Over Alleged AI Copyright Infringement
AstroTurf Expands Footprint at Colorado as Buffaloes Complete Second Installation in 12 Months
Microsoft Plans $50 Billion AI Investment to Accelerate Growth in the Global South
European IT Hardware Stocks to Watch as Gaming Demand Outpaces Smartphones, Says BofA
Freedom Finance and Binance Join Forces in Digital Assets
Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal
Anduril Industries Seeks $8 Billion Funding at $60 Billion Valuation
Reese’s Peanut Butter Cup Recipe Debate: Hershey Responds as Cocoa Prices Shift
Starboard Value Targets Tripadvisor Board Overhaul Amid Stock Slump
India AI Impact Summit 2026: Global Tech CEOs Join World Leaders in New Delhi
Federal Court Fines Mobil Oil Australia A$16 Million for Misleading Fuel Claims
BlueScope Steel Forecasts Stronger Second-Half Earnings, Shares Rise Above Rejected Buyout Offer
Waymo Clarifies Role of Remote Workers Amid U.S. Robotaxi Safety Scrutiny
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings
Mitsui Kinzoku Stock Surges to Record High After Profit Forecast Upgrade and Dividend Increase
NAB Shares Hit Record High as First-Quarter Cash Earnings Jump 16% 



